Clinical characterization of patients with SCD used in a microfluidic flow bioassay
| Age (y) . | Sex . | Race . | SCD genotype . | HbA2 (%) . | HbS (%) . | HbF (%) . | Reticulocyte (%) . | Hydroxyurea . | Voxelotor . |
|---|---|---|---|---|---|---|---|---|---|
| 16 | M | Black/AA | SS | 3 | 84.7 | 12.3 | 12.3 | Y | N |
| 14 | F | Black/AA | SS | 2.9 | 90.1 | 7.0 | 5.8 | Y | Y |
| 16 | F | Black/AA | SS | 2.3 | 71.3 | 17.9 | 12.3 | Y | N |
| 16 | M | Black/AA | SS | 2.6 | 60.3 | 16.0 | 13.5 | Y | Y |
| 7 | F | Middle Eastern | SS | 2.4 | 69.3 | 28.3 | 7.6 | Y | N |
| 14 | M | Black/AA | SS | 2.9 | 76.4 | 20.7 | 9.4 | N | N |
| 7 | M | Black/AA | SS | NM | NM | NM | 18.2 | N | N |
| 15 | M | Black/AA | SS | 3.2 | 84.8 | 12.0 | 10.7 | Y | N |
| 5 | F | Black/AA | SS | 3.3 | 83.7 | 13.0 | 13.8 | Y | N |
| 15 | F | Black/AA | SS | 2.8 | 85.2 | 6.4 | 9.3 | Y | Y |
| Age (y) . | Sex . | Race . | SCD genotype . | HbA2 (%) . | HbS (%) . | HbF (%) . | Reticulocyte (%) . | Hydroxyurea . | Voxelotor . |
|---|---|---|---|---|---|---|---|---|---|
| 16 | M | Black/AA | SS | 3 | 84.7 | 12.3 | 12.3 | Y | N |
| 14 | F | Black/AA | SS | 2.9 | 90.1 | 7.0 | 5.8 | Y | Y |
| 16 | F | Black/AA | SS | 2.3 | 71.3 | 17.9 | 12.3 | Y | N |
| 16 | M | Black/AA | SS | 2.6 | 60.3 | 16.0 | 13.5 | Y | Y |
| 7 | F | Middle Eastern | SS | 2.4 | 69.3 | 28.3 | 7.6 | Y | N |
| 14 | M | Black/AA | SS | 2.9 | 76.4 | 20.7 | 9.4 | N | N |
| 7 | M | Black/AA | SS | NM | NM | NM | 18.2 | N | N |
| 15 | M | Black/AA | SS | 3.2 | 84.8 | 12.0 | 10.7 | Y | N |
| 5 | F | Black/AA | SS | 3.3 | 83.7 | 13.0 | 13.8 | Y | N |
| 15 | F | Black/AA | SS | 2.8 | 85.2 | 6.4 | 9.3 | Y | Y |
AA, African American; F, female; HbA2, hemoglobin A2; M, male; NM, not measured.